Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Dupilumab

Conjunctivitis: 3 case reports

    This is a preview of subscription content, log in to check access.

    Reference

    1. Mareschal A, et al. Dupilumab efficacy and safety in adolescents with moderate-to-severe atopic dermatitis: A case series. Acta Dermato-Venereologica 100: No. 1, Jan 2020. Available from: URL: http://doi.org/10.2340/00015555-3368

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Dupilumab. Reactions Weekly 1791, 103 (2020). https://doi.org/10.1007/s40278-020-74948-4

    Download citation